Metastatic Breast Cancer Research

Protecting the Vulnerable: METAvivor Demands Expanded COVID-19 Vaccine Access for the Metastatic Breast Cancer Community protecting-the-vulnerable-metavivor-demands-expanded-covid-19-vaccine-access-for-the-metastatic-breast-cancer-community

Protecting the Vulnerable: METAvivor Demands Expanded COVID-19 Vaccine Access for the Metastatic Breast Cancer Community

Iffa Jayyana August 17, 2026

May 2026 Advocacy Update As the global medical community prepares for the upcoming respiratory virus season, a...

Bridging the Gap: METAvivor’s Strategic Push for Metastatic Breast Cancer Innovation bridging-the-gap-metavivors-strategic-push-for-metastatic-breast-cancer-innovation-1

Bridging the Gap: METAvivor’s Strategic Push for Metastatic Breast Cancer Innovation

Suro Senen August 16, 2026

By Editorial Staff In the complex, high-stakes world of oncology research, few organizations maintain as consistent a...

Breaking Down Barriers: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act breaking-down-barriers-metavivor-joins-coalition-to-champion-the-clinical-trial-modernization-act

Breaking Down Barriers: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

Nana Muazin August 16, 2026

In a significant move aimed at reshaping the landscape of medical research, the metastatic breast cancer advocacy...

Beyond the Diagnosis: Bionews Launches "The Rare Journey" to Humanize the Rare Disease Experience beyond-the-diagnosis-bionews-launches-the-rare-journey-to-humanize-the-rare-disease-experience

Beyond the Diagnosis: Bionews Launches "The Rare Journey" to Humanize the Rare Disease Experience

Lina Hope August 16, 2026

PENSACOLA, Florida — August 19, 2024 — For the millions of individuals navigating the labyrinthine world of...

Advocacy in Crisis: METAvivor Challenges Proposed Rescission of Vital PCORI Research Funding advocacy-in-crisis-metavivor-challenges-proposed-rescission-of-vital-pcori-research-funding

Advocacy in Crisis: METAvivor Challenges Proposed Rescission of Vital PCORI Research Funding

Nana Wu August 13, 2026

The landscape of metastatic breast cancer (MBC) research faces a precarious turning point as advocacy groups rally...

Bridging the Data Gap: METAvivor and the Coalition Urging Modernization of America’s Cancer Registries bridging-the-data-gap-metavivor-and-the-coalition-urging-modernization-of-americas-cancer-registries

Bridging the Data Gap: METAvivor and the Coalition Urging Modernization of America’s Cancer Registries

Lina Irawan August 13, 2026

In the ongoing battle against cancer, data acts as the ultimate compass. For decades, the United States...

Advancing the Frontlines: A Mid-Year Update on Research Funding and Advocacy advancing-the-frontlines-a-mid-year-update-on-research-funding-and-advocacy

Advancing the Frontlines: A Mid-Year Update on Research Funding and Advocacy

Siti Muinah August 10, 2026

Introduction: The Pulse of the Mission In the high-stakes world of medical research, progress is rarely measured...

Advocacy Alert: Navigating the FY 2027 Budget Landscape and Leadership Transitions in Public Health advocacy-alert-navigating-the-fy-2027-budget-landscape-and-leadership-transitions-in-public-health

Advocacy Alert: Navigating the FY 2027 Budget Landscape and Leadership Transitions in Public Health

Nana Muazin August 10, 2026

By the METAvivor Advocacy Team As the legislative gears of Washington, D.C., grind back into motion following...

Protecting the Pipeline: METAvivor Challenges Proposed Revisions to Federal Research Funding protecting-the-pipeline-metavivor-challenges-proposed-revisions-to-federal-research-funding

Protecting the Pipeline: METAvivor Challenges Proposed Revisions to Federal Research Funding

Laily UPN August 7, 2026

In a decisive move to safeguard the future of biomedical innovation, METAvivor—a leading advocacy organization dedicated to...

Critical Funding at Risk: METAvivor Challenges Proposed Rescission of PCORI Trust Fund critical-funding-at-risk-metavivor-challenges-proposed-rescission-of-pcori-trust-fund

Critical Funding at Risk: METAvivor Challenges Proposed Rescission of PCORI Trust Fund

Reynand Wu August 6, 2026

The landscape of medical research in the United States stands at a precarious crossroads. METAvivor, the leading...

Metastatic Breast Cancer Research

Protecting the Vulnerable: METAvivor Demands Expanded COVID-19 Vaccine Access for the Metastatic Breast Cancer Community

Bridging the Gap: METAvivor’s Strategic Push for Metastatic Breast Cancer Innovation

Breaking Down Barriers: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

Beyond the Diagnosis: Bionews Launches "The Rare Journey" to Humanize the Rare Disease Experience

Advocacy in Crisis: METAvivor Challenges Proposed Rescission of Vital PCORI Research Funding

Bridging the Data Gap: METAvivor and the Coalition Urging Modernization of America’s Cancer Registries

Advancing the Frontlines: A Mid-Year Update on Research Funding and Advocacy

Advocacy Alert: Navigating the FY 2027 Budget Landscape and Leadership Transitions in Public Health

Protecting the Pipeline: METAvivor Challenges Proposed Revisions to Federal Research Funding

Critical Funding at Risk: METAvivor Challenges Proposed Rescission of PCORI Trust Fund

You may have missed

Biopharma Industry Update: Safety Hurdles, Geopolitical Shifts, and Strategic Acquisitions

A Synergistic Shield: The Netherlands and WHO Forge Deeper Ties to Combat the Climate-Health Crisis

Revolutionizing Breast Cancer Screening: Landmark Study Advocates Personalized Risk-Based Approach Over Universal Guidelines

ESMO26: Amgen’s Imdelltra posts win in first-line SCLC maintenance setting